NRx Pharmaceuticals (NRXP) Institutional Ownership $2.52 +0.06 (+2.44%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.55 +0.03 (+1.19%) As of 08/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NRx Pharmaceuticals (NASDAQ:NRXP)CurrentInstitutional OwnershipPercentage4.27%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$5.10MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$74.98K Get NRXP Insider Trade Alerts Want to know when executives and insiders are buying or selling NRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRXP Institutional Buying and Selling by Quarter NRx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2025Geode Capital Management LLC172,255$562K0.0%+27.9%0.996% 8/4/2025 AdvisorShares Investments LLC263,797$860K0.2%-8.0%1.526% 5/28/2025Anson Funds Management LP1,179,061$2.42M0.4%+535.1%6.820% 5/14/2025Anson Funds Management LP1,179,061$2.42M0.3%+535.1%6.845% 2/17/2025Squarepoint Ops LLC25,299$56K0.0%N/A0.161% 2/17/2025Millennium Management LLC27,624$61K0.0%N/A0.176% 2/17/2025Anson Funds Management LP185,660$408K0.0%+30.3%1.183% 2/14/2025 AdvisorShares Investments LLC310,314$683K0.1%+138.5%1.977% 2/14/2025Sassicaia Capital Advisers LLC15,000$33K0.8%N/A0.096% 11/15/2024Anson Funds Management LP142,525$241K0.0%N/A1.326% Get the Latest News and Ratings for NRXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024Townsquare Capital LLC15,041$25K0.0%N/A0.140% 8/8/2024 AdvisorShares Investments LLC108,085$279K0.0%-82.4%1.010% 8/6/2024 One Wealth Management Investment & Advisory Services LLC15,041$37K0.0%-89.3%0.141% 2/14/2024 AdvisorShares Investments LLC642,632$296K0.1%N/A0.755% 1/25/2024 One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165% 11/15/2023Sabby Management LLC325,000$84K0.1%-53.6%0.398% 5/1/2023Virtu Financial LLC46,210$30K0.0%N/A0.065% 2/9/2023 HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086% 1/31/2023 AE Wealth Management LLC29,515$33K0.0%N/A0.044% 1/27/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 1/18/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 11/3/2022Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094% 5/18/2022Ursa Fund Management LLC15,000$37K0.0%N/A0.023% 4/29/2022United Asset Strategies Inc.18,300$45K0.0%N/A0.027% 2/9/2022 Wolverine Asset Management LLC37,105$177K0.0%-12.8%0.063% 2/8/2022Raymond James Financial Services Advisors Inc.11,567$55K0.0%N/A0.020% 11/15/2021 Penserra Capital Management LLC2,956$27K0.0%N/A0.005% 11/12/2021 Wolverine Asset Management LLC42,568$394K0.0%+118.4%0.079% 11/5/2021Advisor Group Holdings Inc.42,885$398K0.0%+1,197.6%0.080% 11/2/2021 Cambridge Investment Research Advisors Inc.153,523$1.42M0.0%N/A0.285% 8/16/2021Owl Creek Asset Management L.P.300,000$3.40M0.2%N/A0.626% 8/16/2021Ionic Capital Management LLC35,721$415K0.0%N/A0.075% 8/16/2021Linden Advisors LP364,352$4.23M0.0%N/A0.760% 8/13/2021Northern Trust Corp130,633$1.52M0.0%N/A0.273% 8/13/2021Yakira Capital Management Inc.11,923$139K0.0%N/A0.025% 8/13/2021Geode Capital Management LLC34,475$400K0.0%N/A0.072% 8/13/2021Vanguard Group Inc.637,416$7.41M0.0%N/A1.330% (Data available from 1/1/2016 forward) NRXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRXP shares? During the previous two years, 9 institutional investors and hedge funds held shares of NRx Pharmaceuticals. The most heavily invested institutionals were Anson Funds Management LP ($2.42M), AdvisorShares Investments LLC ($860K), Geode Capital Management LLC ($562K), Sabby Management LLC ($84K), Millennium Management LLC ($61K), Squarepoint Ops LLC ($56K), and One Wealth Management Investment & Advisory Services LLC ($37K).Learn more on NRx Pharmaceuticals' institutional investors. What percentage of NRx Pharmaceuticals' stock is owned by institutional investors? 4.27% of NRx Pharmaceuticals' stock is owned by institutional investors. Learn more on NRXP's institutional investor holdings. Which institutional investors have been buying NRx Pharmaceuticals' stock? The following institutional investors have purchased NRx Pharmaceuticals' stock in the last 24 months: Anson Funds Management LP ($2.17M), AdvisorShares Investments LLC ($822.86K), One Wealth Management Investment & Advisory Services LLC ($140.40K), Geode Capital Management LLC ($37.60K), Millennium Management LLC ($27.62K), Squarepoint Ops LLC ($25.30K), and Townsquare Capital LLC ($15.04K). How much institutional buying is happening at NRx Pharmaceuticals? Institutional investors have bought a total of 2,473,253 shares in the last 24 months. This purchase volume represents approximately $5.10M in transactions. Which of NRx Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold NRx Pharmaceuticals stock in the last 24 months: AdvisorShares Investments LLC ($23K). How much institutional selling is happening at NRx Pharmaceuticals? Institutional investors have sold a total of 23,000 shares in the last 24 months. This volume of shares sold represents approximately $74.98K in transactions. Related Companies Organigram Global Major Shareholders DiaMedica Therapeutics Major Shareholders Cardiff Oncology Major Shareholders Rapt Therapeutics Major Shareholders Lyell Immunopharma Major Shareholders Aclaris Therapeutics Major Shareholders SELLAS Life Sciences Group Major Shareholders Cellectis Major Shareholders Voyager Therapeutics Major Shareholders Journey Medical Major Shareholders This page (NASDAQ:NRXP) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
